Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: Comparison with oral corticosteroids

Auris Nasus Larynx

Volumn 40, Issue 3, 2013, Pages 277-281

  Karaki, Masayuki ^a   Akiyama, Kosuke ^a   Mori, Nozomu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Allergic rhinitis; Efficacy; Side effect; Topical oral corticosteroid

Indexed keywords

BETAMETHASONE; IMMUNOGLOBULIN E; LORATADINE; MOMETASONE FUROATE;

ADRENAL CORTEX INSUFFICIENCY; ADULT; AGED; ANAPHYLAXIS; ARTHRALGIA; ARTICLE; BILIRUBIN BLOOD LEVEL; BONE NECROSIS; CATARACT; CONTROLLED STUDY; COUGHING; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DISEASE EXACERBATION; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; EOSINOPHIL; EPISTAXIS; FEMALE; GLAUCOMA; HAY FEVER; HUMAN; JAPANESE CEDAR; LARYNGITIS; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; MOON FACE; MUSCLE CRAMP; MYALGIA; MYOPATHY; NASAL PRURITUS; NAUSEA; NOSE DISEASE; NOSE OBSTRUCTION; OCULAR PRURITUS; OSTEOPOROSIS; PANCREATITIS; POLYDIPSIA; QUALITY OF LIFE; QUESTIONNAIRE; RHINORRHEA; SIDE EFFECT; SNEEZING; SOMNOLENCE; STOMACH PAIN; SYMPTOMATOLOGY; THROMBOSIS; VOMITING;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADULT; AGED; ANTI-ALLERGIC AGENTS; BETAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; LORATADINE; MALE; MIDDLE AGED; NASAL OBSTRUCTION; PREGNADIENEDIOLS; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

EID: 84875814140     PISSN: 03858146     EISSN: 18791476     Source Type: Journal    
DOI: 10.1016/j.anl.2012.09.004     Document Type: Article

References (18)

1. Murayama K., Baba K., Okubo K. Regional differences in the prevalence of Japanese cedar-pollen allergy. Arerugi 2010, 59:47-54.
2. Rizzo M.C., Sole D., Naspitz C.K. Corticosteriods (inhaled and/or intranasal) in the treatment of respiratory allergic in children: safety vs. efficacy. Allergol Immunopathol 2007, 35:197-208.
3. Zitt M., Kosoglou T., Hubbell J. Mometasone furoate nasal spray: a review of safety and systemic effects. Drug Saf 2007, 30:317-326.
4. Stanbury R.M., Graham E.M. Systemic corticosteroid therapy: side effects and their management. Br J Opthalmol 1998, 82:704-708.
5. Tattersfield A.E., Harrison T.W., Hubbard R.B., Hubbard R.B., Mortimer K. Safety of inhaled corticosteroids. Proc Am Thorac Soc 2004, 1:171-175.
6. Lipworth B.J., Jackson C.M. Safety of inhaled and intranasal corticosteroids: lessons the new millennium. Drug Saf 2000, 23:11-33.
7. Meltzer E.O., Berger W.E., Berkowitz R.B., Bronsky E.A., Dvorin D.J., Finn A.F., et al. A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis. J Allergy Clin Immunol 1996, 77:153-160.
8. Schenkel E.J., Skoner D.P., Bronsky E.A., Miller S.D., Pearlman D.S., Rooklin A., et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000, 105:E22.
9. Meltzer E.O., Jalowayski A.A., Orgel H.A., Harris A.G. Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray. J Allergy Clin Immunol 1998, 102:39-49.
10. Lipworth B.J., Seckl J.R. Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids. Thorax 1997, 52:476-482.
11. Dibildox J. safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: results of recent clinical trials. J Allergy Clin Immunol 2001, 108:S54-S58.
12. Teng X.W., Cutler D.J., Davies N.M. Mometasone furoate degradation and metabolism in human biological fluids and tissues. Biopharm Drug Dispos 2003, 90:56-62.
13. Baena-Cagnani C.E., Patel P. Efficacy and long-term safety of mometasone furoate nasal spray in children with perennial allergy rhinitis. Curr Med Res Opin 2010, 26:2047-2055.
14. Okubo K., Kurono Y., Fujieda S., Ogino S., Uchio E., Odajima H., et al. Japanese Society of Allergology. Japanese guideline for allergic rhinitis. Allergol Int 2011, 60:171-189.
15. Fujieda S., Kurono Y., Okubo K., Ichimura K., Enomoto T., Kawauchi H., et al. Examination, diagnosis and classification for Japanese allergic rhinitis: Japanese guideline. Auris Nasus Larynx 2012, 39:553-556.
16. Schenkel E., LaForce C., Gates D. Mometasone furoate nasal spray in seasonal allergic rhinitis: effective in relieving ocular symptoms. Allergy Clin Immunol Int-J World Allergy Org 2007, 19:50-53.
17. Bielory L. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate. Ann Allergy Asthma Immunol 2008, 100:272-279.
18. Anolik R., Pearlman D., Teper A., Gates D. Mometasone furoate improves nasal and ocular symptoms of seasonal allergic rhinitis in adolescents. Allergy Asthma Proc 2009, 30:406-412.